Drugs

Published by: Adis International Ltd  

People

  1. Abramson
    Abramson
  2. Chen
    Chen
  3. Drilon
    Drilon
  4. Dunkel
    Dunkel
  5. Gulati
    Gulati
  6. Hudis
    Hudis
  7. Lake
    Lake
  8. Moryl
    Moryl
  9. Motzer
    Motzer
  10. O'Reilly
    O'Reilly

Groups

  1. Department of Medicine (7)
  2. Solid Tumor Oncology Division (6)
  3. Gastrointestinal Oncology Service (3)
  4. Survivorship Research (3)
  5. Center for Pancreatic Cancer Research (2)
  6. GME, Medicine (2)
  7. Graduate Medical Education (2)
  8. Hematology-Oncology Fellows (2)
  9. Adult Leukemia (1)
  10. Anesthesiology Service (1)
Search Within
Formats
  1. Journal Article (10)
  2. Review (5)
Groups
  1. Department of Medicine (7)
  2. Solid Tumor Oncology Division (6)
  3. Gastrointestinal Oncology Service (3)
  4. Survivorship Research (3)
  5. Center for Pancreatic Cancer Research (2)
  6. GME, Medicine (2)

More Groups

People
  1. Alan Yagoda (1)
  2. Alexander Drilon (1)
  3. Amitabh Gulati (1)
  4. Anthony Mato (1)
  5. Clare Wilhelm (1)
  6. Clifford Hudis (1)

More People

Years
  1. 2024 (1)
  2. 2022 (3)
  3. 2020 (1)
  4. 2018 (1)
  5. 2011 (1)
  6. 2008 (1)

More Years

Publishers
  1. Adis International Ltd (15)

Results (15)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • RET inhibitors in RET fusion-positive lung cancers: Past, present, and future
    Review

    Chen, M. F.; Repetto, M.; Wilhelm, C.; Drilon, A.
    Drugs (2024)

    Fulltext@MSK | Save
  • BCMA-targeted biologic therapies: The next standard of care in multiple myeloma therapy
    Review

    Paul, B.; Rodriguez, C.; Usmani, S. Z.
    Drugs (2022)

    Fulltext@MSK | Save
  • Pharmacologic management of persistent pain in cancer survivors
    Review

    Glare, P.; Aubrey, K.; Gulati, A.; Lee, Y. C.; Moryl, N.; Overton, S.
    Drugs (2022)

    Fulltext@MSK | Save
  • Current treatment of chronic lymphocytic leukemia: The diminishing role of chemoimmunotherapy
    Review

    Roeker, L. E.; Thompson, M.; Mato, A. R.
    Drugs (2022)

    Fulltext@MSK | Save
  • New treatment strategies for metastatic pancreatic ductal adenocarcinoma
    Review

    Singh, R. R.; O’Reilly, E. M.
    Drugs (2020)

    Fulltext@MSK | Save
  • Treating chronic pain: An overview of clinical studies centered on the buprenorphine option
    Journal Article

    Davis, M. P.; Pasternak, G.; Behm, B.
    Drugs (2018)

    Fulltext@MSK | Save
  • Potential synergies for combined targeted therapy in the treatment of neuroendocrine cancer
    Journal Article

    Salazar, R.; Reidy-Lagunes, D.; Yao, J.
    Drugs (2011)

    Fulltext@MSK | Save
  • Treatment of nausea and vomiting in terminally ill cancer patients
    Journal Article

    Glare, P. A.; Dunwoodie, D.; Clark, K.; Ward, A.; Yates, P.; Ryan, S.; Hardy, J. R.
    Drugs (2008)

    Fulltext@MSK | Save
  • Current management strategies for intraocular retinoblastoma
    Journal Article

    Kim, J. W.; Abramson, D. H.; Dunkel, I. J.
    Drugs (2007)

    Fulltext@MSK | Save
  • Sunitinib: A viewpoint by Robert J. Motzer
    Journal Article

    Motzer, R. J.
    Drugs (2006)

    Fulltext@MSK | Save

    • Drugs – authorized name for:

    Name ISSN / ISBN Publisher
    Drugs 0012-6667 Unknown
    Drugs 0012-6667 Adis International Ltd
    Drugs 00126667 2018, Springer Nature Switzerland Ag
    Drugs 00126667 The Author(s), Under Exclusive Licence To Springer Nature Switzerland Ag 2024
    Drugs 0012-6667 Adis Data Information Bv
    Drugs 0012-6667 Adis International Ltd
    Drugs 00126667 2022, The Author(s), Under Exclusive Licence To Springer Nature Switzerland Ag
    Drugs 0012-6667 Adis International Ltd
    Drugs 0012-6667 Adis Int Ltd
    Drugs 00126667 Unknown
    Drugs 00126667 2021, The Author(s), Under Exclusive Licence To Springer Nature Switzerland Ag
    Drugs 0012-6667 Adis International Ltd